Cargando…
A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
INTRODUCTION: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594886/ https://www.ncbi.nlm.nih.gov/pubmed/34803412 http://dx.doi.org/10.2147/RMHP.S339408 |
_version_ | 1784600078081589248 |
---|---|
author | Musoke, Phillip Okot, Jerom Nanfuka, Vivien Rwamafa, Pius Masajjage, Joseph Kisuule, Ivan Nantaayi, Brandy Ssewante, Nelson Bongomin, Felix |
author_facet | Musoke, Phillip Okot, Jerom Nanfuka, Vivien Rwamafa, Pius Masajjage, Joseph Kisuule, Ivan Nantaayi, Brandy Ssewante, Nelson Bongomin, Felix |
author_sort | Musoke, Phillip |
collection | PubMed |
description | INTRODUCTION: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda. METHODS: A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers’ exact test for categorical and Mann–Whitney U-test for numerical were used to determine the association between dependent and independent variables. RESULTS: The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range: 20–75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR): 3.1, 95% confidence interval (CI): 1.4–6.8, p = 0.005) and having attained tertiary level of education (aOR: 6.2, 95% CI: 1.7–23.1, p = 0.006), as well as the accessibility to herbalists (aOR: 31.2, 95% CI: 3.7–263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53). CONCLUSION: The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy. |
format | Online Article Text |
id | pubmed-8594886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85948862021-11-18 A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda Musoke, Phillip Okot, Jerom Nanfuka, Vivien Rwamafa, Pius Masajjage, Joseph Kisuule, Ivan Nantaayi, Brandy Ssewante, Nelson Bongomin, Felix Risk Manag Healthc Policy Original Research INTRODUCTION: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda. METHODS: A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers’ exact test for categorical and Mann–Whitney U-test for numerical were used to determine the association between dependent and independent variables. RESULTS: The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range: 20–75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR): 3.1, 95% confidence interval (CI): 1.4–6.8, p = 0.005) and having attained tertiary level of education (aOR: 6.2, 95% CI: 1.7–23.1, p = 0.006), as well as the accessibility to herbalists (aOR: 31.2, 95% CI: 3.7–263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53). CONCLUSION: The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy. Dove 2021-11-12 /pmc/articles/PMC8594886/ /pubmed/34803412 http://dx.doi.org/10.2147/RMHP.S339408 Text en © 2021 Musoke et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Musoke, Phillip Okot, Jerom Nanfuka, Vivien Rwamafa, Pius Masajjage, Joseph Kisuule, Ivan Nantaayi, Brandy Ssewante, Nelson Bongomin, Felix A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda |
title | A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda |
title_full | A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda |
title_fullStr | A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda |
title_full_unstemmed | A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda |
title_short | A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda |
title_sort | preliminary report on herbal medicine use among patients hospitalized at two-large covid-19 treatment centers in uganda |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594886/ https://www.ncbi.nlm.nih.gov/pubmed/34803412 http://dx.doi.org/10.2147/RMHP.S339408 |
work_keys_str_mv | AT musokephillip apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT okotjerom apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT nanfukavivien apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT rwamafapius apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT masajjagejoseph apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT kisuuleivan apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT nantaayibrandy apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT ssewantenelson apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT bongominfelix apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT musokephillip preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT okotjerom preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT nanfukavivien preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT rwamafapius preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT masajjagejoseph preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT kisuuleivan preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT nantaayibrandy preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT ssewantenelson preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda AT bongominfelix preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda |